Helicobacter pylori: Host genetics and disease outcomes

Expert Review of Gastroenterology and Hepatology

Volumn 2, Issue 4, 2008, Pages 577-585

  Snaith, Ailsa ^a   El Omar, Emad M ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Cytokine; Gastric cancer; Gastritis; Helicobacter pylori; Host genetics; Peptic ulcer disease; Polymorphism

Indexed keywords

BACTERIAL DNA; CYTOKINE; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 1BETA; TOLL LIKE RECEPTOR 4;

ACHLORHYDRIA; CANCER RISK; CANCER SUSCEPTIBILITY; CHRONIC INFLAMMATION; DISEASE SEVERITY; DNA POLYMORPHISM; DUODENUM ULCER; GASTRITIS; GENE CLUSTER; GENE IDENTIFICATION; GENETIC MARKER; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HEREDITY; HOST RESISTANCE; HUMAN; INFECTION RISK; INNATE IMMUNITY; NONHUMAN; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PEPTIC ULCER; PHENOTYPE; REVIEW; RISK ASSESSMENT; STOMACH ACID SECRETION; STOMACH CANCER; STOMACH CARCINOGENESIS;

DISEASE PROGRESSION; GENETIC PREDISPOSITION TO DISEASE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; PEPTIC ULCER; POLYMORPHISM, GENETIC; STOMACH NEOPLASMS;

EID: 55649091192     PISSN: 17474124     EISSN: None     Source Type: Journal    
DOI: 10.1586/17474124.2.4.577     Document Type: Review

References (67)

1. Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1, 1311-1315 (1984).
2. IARC monographs on the evaluation of carcinogenic risks to humans, Vol. 61. Schistosomes, liver flukes and Helicobacter pylori. IARC, Lyon, France, 177-240 (1994).
3. Malaty HM, El-Kasabany A, Graham DY et al. Age at acquisition of Helicobacter pylori infection: a follow-up study from infancy to adulthood. Lancet 359, 931-935 (2002).
4. Parsonnet J, Shmuely H, Haggerty T. Fecal and oral shedding of Helicobacter pylori from healthy infected adults. JAMA 282, 2240-2245 (1999).
5. Taylor DN, Blaser MJ. The epidemiology of Helicobacter pylori infection. Epidemiol. Rev. 13, 42-59 (1991).
6. Freeman HJ. Disappearance of Helicobacter without antibiotics in 12 patients with gastritis. Can. J. Gastroenterol. 11, 167-172 (1997).
7. Tham TC, Sloan JM, Collins JS. Long-term semi-quantitative follow-up of Helicobacter pylori associated gastritis. Ir. J. Med. Sci. 166, 132-134 (1997)
8. Amieva MR, El-Omar EM. Host-bacterial interactions in Helicobacter pylori infection. Gastroenterology 134, 306-323 (2008).
9. Graham DY, Opekun AR, Osato MS et al. Challenge model for Helicobacter pylori infection in human volunteers. Gut 53, 1235-1243 (2004).
10. Danon SJ, O'Rourke JL, Moss ND et al. The importance of local acid production in the distribution of Helicobacter felis in the mouse stomach. Gastroenterology 108, 1386-1395 (1995).
11. Kuipers EJ, Lundell L, Klinkenberg-Knol EC et al. Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication. N. Engl. J. Med. 334, 1018-1022 (1996).
12. Israel DA, Peek RM. Pathogenesis of Helicobacter pylori-induced gastric inflammation. Aliment Pharmacol. Ther. 15, 1271-1290 (2001).
13. Robert A, Olafsson AS, Lancaster C et al. Interleukin-1 is cytoprotective, antisecretory, stimulates PGE2 synthesis by the stomach, and retards gastric emptying. Life Sci. 48, 123-134 (1991).
14. Wolfe MM, Nompleggi DJ. Cytokine inhibition of gastric acid secretion - a little goes a long way. Gastroenterolagy 102, 2177-2178 (1992).
15. Beales IL, Calam J. Interleukin 1 β and tumour necrosis factor a inhibit acid secretion in cultured rabbit parietal cells by multiple pathways. Gut 42, 227-234 (1998).
16. El-Omar EM, Oien K, El Nujumi A et al. Helicobacter pylori infection and chronic gastric acid hyposecretion. Gastroenterology 113, 15-24 (1997).
17. El-Omar EM, Penman ID, Ardill JE et al. Helicobacter pylori infection and abnormalities of acid secretion in patients with duodenal ulcer disease. Gastroenterology 109, 681-691 (1995).
18. McColl KE, El-Omar E, Gillen D. Helicobacter pylori gastritis and gastric physiology. Gastroenterol. Clin. North Am. 29, 687-703 (2000).
19. Danon SJ, O'Rourke JL, Moss ND et al. The importance of local acid production in the distribution of Helicobacter felis in the mouse stomach. Gastroenterology 108, 1386-1395 (1995).
20. Lundell L, Havu N, Miettinen P et al. Changes of gastric mucosal architecture during long-term omeprazole therapy: results of a randomized clinical trial. Aliment Pharmacol. Ther. 23, 639-647 (2006).
21. Kuipers EJ. Proton pump inhibitors and gastric neoplasia. Gut 55, 1217-1221 (2006).
22. Kuipers EJ, Klinkenberg-Knol EC, Meuwissen SG. Omeprazole and accelerated onset of atrophic gastritis. Gastroenterology 118, 239-242 (2000).
23. Malaty HM, Engstrand L, Pedersen NL et al. Helicobacter pylori infection: genetic and environmental influences. A study of twins. Ann. Intern. Med. 120, 982-986 (1994).
24. Tseng FC, Brown EE, Maiese EM et al. Polymorphisms in cytokine genes and risk of Helicobacter pylori infection among Jamaican children. Helicobacter 11, 425-430 (2006).
25. Liou JM, Lin JT, Wang HP et al. IL-1B-511 C-->T polymorphism is associated with increased host susceptibility to Helicobacter pylori infection in Chinese. Helicobacter 12, 142-149 (2007).
26. Parkin DM, Bray F, Ferlay J et al. Global cancer statistics, 2002. CA Cancer J. Clin. 55, 74-108 (2005).
27. Graham DY, Yamaoka Y. Disease-specific Helicobacter pylori virulence factors: the unfulfilled promise. Helicobacter 5(Suppl. 1), S3-S9 (2000).
28. Dinarello CA. Biologic basis for interleukin-1 in disease. Blood 87, 2095-2147 (1996).
29. El-Omar EM. The importance of interleukin 1β in Helicobacter pylori associated disease. Gut 48, 743-747 (2001).
30. Bidwell J, Keen L, Gallagher G et al. Cytokine gene polymorphism in human disease: on-line databases, supplement 1. Genes Immun. 2, 61-70 (2001).
31. El-Omar EM, Carrington M, Chow WH et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 404, 398-402 (2000)
32. El-Omar EM, Rabkin CS, Gammon MD et al. Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. Gastroenterology 124, 1193-1201 (2003).
33. Machado JC, Pharoah P, Sousa S et al. Interleukin 1B and interleukin 1RN polymorphisms are associated with increased risk of gastric carcinoma. Gastroenterology 121, 823-829 (2001).
34. Figueiredo C, Machado JC, Pharoah P et al. Helicobacter pylori and interleukin 1 genotyping: an opportunity to identify high-risk individuals for gastric carcinoma. J. Natl Cancer Inst. 94, 1680-1687 (2002).
35. Machado JC, Figueiredo C, Canedo P et al. A proinflammatory genetic profile increases the risk for chronic atrophic gastritis and gastric carcinoma. Gastroenterology 125, 364-371 (2003).
36. Rad R, Prinz C, Neu B et al. Synergistic effect of Helicobacter pylori virulence factors and interleukin-1 polymorphisms for the development of severe histological changes in the gastric mucosa. J. Infect. Dis. 188, 272-281 (2003).
37. Palli D, Saieva C, Luzzi I et al. Interleukin-1 gene polymorphisms and gastric cancer risk in a high-risk Italian population. Am. J. Gastroenterol. 100, 1941-1948 (2005).
38. Furuta T, El-Omar EM, Xiao F et al. Interleukin 1β polymorphisms increase risk of hypochlorhydria and atrophic gastritis and reduce risk of duodenal ulcer recurrence in Japan. Gastroenterology 123, 92-105 (2002).
39. Zeng ZR, Hu PJ, Hu Set al. Association of interleukin 1B gene polymorphism and gastric cancers in high and low prevalence regions in China. Gut 52, 1684-1689 (2003).
40. Lee KA, Ki CS, Kim HJ et al. Novel interleukin 1β polymorphism increased the risk of gastric cancer in a Korean population. J. Gastroenterol. 39, 429-433 (2004).
41. Chang YW, Jang JY, Kim N H et al. Interleukin-1B (IL-1B) polymorphisms and gastric mucosal levels of IL-1β cytokine in Korean patients with gastric cancer. Int. J. Cancer 114, 465-471 (2005).
42. Yang J, Hu Z, Xu Y et al. Interleukin-1B gene promoter variants are associated with an increased risk of gastric cancer in a Chinese population. Cancer Lett. 215, 191-198 (2004).
43. Chen HM, Wilkins LM, Aziz N et al. Single nucleotide polymorphisms in the human interleukin-1B gene affect transcription according to haplotype context. Hum. Mol. Genet. 15, 519-529 (2006).
44. Lee KA, Park JH, Sohn TS et al. Interaction of polymorphisms in the Interleukin 1B-31 and general transcription factor 2A1 genes on the susceptibility to gastric cancer. Cytokine 38, 96-100 (2007).
45. Shen J, Arnett DK, Peacock JM et al. Interleukin 1β genetic polymorphisms interact with polyunsaturated fatty acids to modulate risk of the metabolic syndrome. J. Nutr. 137, 1846-1851 (2007).
46. Tu, S, Cui G, Takaishi S et al. Overexpression of human interleukin-1β in transgenic mice results in spontaneous gastric inflammation and carcinogenesis, Gastroenterology 128(4 Suppl. 2), A62 (2005).
47. Lu W, Pan K, Zhang L et al. Genetic polymorphisms of interleukin (IL)-IB, IL-1RN, IL-8, IL-10 and tumor necrosis factor α and risk of gastric cancer in a Chinese population. Carcinogenesis 26, 631-636 (2005).
48. Taguchi A, Ohmiya N, Shirai K et al. Interleukin-8 promoter polymorphism increases the risk of atrophic gastritis and gastric cancer in Japan. Cancer Epidemiol. Biomarkers Prev. 14, 2487-2493 (2005).
49. Lee WP, Tai DI, Lan KH et al. The -251T allele of the interleukin-8 promoter is associated with increased risk of gastric carcinoma featuring diffuse-type histopathology in Chinese population. Clin. Cancer Res. 11, 6431-6441 (2005).
50. Ohyauchi M, Imatani A, Yonechi M et al. The polymorphism interleukin 8 -251 A/T influences the susceptibility of Helicobacter pylori related gastric diseases in the Japanese population. Gut 54, 330-335 (2005).
51. Kuipers EJ. Review article: exploring the link between Helicobacter pylori and gastric cancer. Aliment Pharmacol. Ther. 13(Suppl. 1), 3-11 (1999).
52. Segal ED, Lange C, Covacci A et al. Induction of host signal transduction pathways by Helicobacter pylori. Proc. Natl Acad. Sci. USA 94, 7595-7599 (1997).
53. Su B, Ceponis PJ, Lebel S et al. Helicobacter pylori activates Toll-like receptor 4 expression in gastrointestinal epithelial cells. Infect. Immun. 71, 3496-3502 (2003).
54. Pasare C, Medzhitov R. Toll-like receptors: linking innate and adaptive immunity. Adv. Exp. Med. Biol. 560, 11-18 (2005).
55. Takeda K, Akira S. Toll-like receptors in innate immunity. Int. Immunol. 17, 1-14 (2005).
56. Arbour NC, Lorenz E, Schutte BC et al. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat. Genet. 25, 187-191 (2000).
57. Franchimont D, Vermeire S, El Housni H et al. Deficient host-bacteria interactions in inflammatory bowel disease? The Toll-like receptor (TLR)-4 Asp299gly polymorphism is associated with Crohn's disease and ulcerative colitis. Gut 53, 987-992 (2004).
58. Lorenz E, Mira JP, Frees KL et al. Relevance of mutations in the TLR4 receptor in patients with Gram-negative septic shock. Arch. Intern. Med. 162, 1028-1032 (2002).
59. Kiechl S, Lorenz E, Reindl M et al. Toll-like receptor 4 polymorphisms and atherogenesis. N. Engl. J. Med. 347, 185-192 (2002).
60. Higgins SC, Lavelle EC, McCann C et al. Toll-like receptor 4-mediated innate IL-10 activates antigen-specific regulatory T cells and confers resistance to Bordetella pertussis by inhibiting inflammatory pathology. J. Immunol. 171, 3119-3127 (2003).
61. Hold GL, Rabkin CS, Chow WH et al. A functional polymorphism of Toll-like receptor 4 gene increases risk of gastric carcinoma and its precursors. Gastroenterology 132, 905-912 (2007).
62. Sanduleanu S, Jonkers D, De Bruine A et al. Double gastric infection with Helicobacter pylori and non-Helicobacter pylori bacteria during acid-suppressive therapy: increase of pro-inflammatory cytokines and development of atrophic gastritis. Aliment. Pharmacol. Ther. 15, 1163-1175 (2001).
63. Zavros Y, Rieder G, Ferguson A et al. Genetic or chemical hypochlorhydria is associated with inflammation that modulates parietal and G-cell populations in mice. Gastroenterology 122, 119-133 (2002).
64. Baccarelli A, Hou L, Chen J et al. Mannose-binding lectin-2 genetic variation and stomach cancer risk. Int. J. Cancer 119, 1970-1975 (2006).
65. Zanke BW, Greenwood CM, Rangrej J et al. Genome-wide association scan identifies a colorectal cancer susceptibility locus on chromosome 8q24. Nat. Genet. 39, 989-994 (2007).
66. Haiman CA, Le Marchand L, Yamamato J et al. A common genetic risk factor for colorectal and prostate cancer. Nat. Genet. 39, 954-956 (2007).
67. Tomlinson I, Webb E, Carvajal-Carmona L et al. A genome-wide association scan of tag SNPs identifies a susceptibility variant for colorectal cancer at 8q24.21, Nat. Genet. 39, 984-988 (2007).